CLEC11A and invasive breast carcinoma: We observed that the CLEC11A expression was significantly elevated in breast invasive carcinoma, cholangiocarcinoma, colon adenocarcinoma, head and neck squamous cell carcinoma, LUAD, prostate adenocarcinoma, and STAD.